MetGenX annotates two previously uncharacterized metabolites in mouse liver
MetGenX, a structure-informed neural-network workflow for generating structures from tandem mass spectra, was applied to untargeted mouse-liver metabolomics and reported two previously uncharacterized metabolites, adenosyl-cysteine and adenosine 5′-diphosphate 5′-inosine (Ap2I). The paper reports validation against chemical standards using retention time and MS2 spectral matches.
Technology: MetGenX structure-informed encoder-decoder neural network with LightGBM reranking
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: MetGenX, a structure-informed neural-network workflow for generating structures from tandem mass spectra, was applied to untargeted mouse-liver metabolomics and reported two previously uncharacterized metabolites, adenosyl-cysteine and adenosine 5′-diphosphate 5′-inosine (Ap2I).
- Still unknown: The original Nature full-text route was inaccessible in this session; the primary-source PubMed article page provides the paper abstract and figure captions describing standard-based retention-time/MS2 matches for the two structures. The finding is metabolite annotation in mouse tissue, not evidence of human biological function. Independent replication was not checked.
- AI role: The model generated and reranked candidate molecular structures from MS2 spectra; researchers applied a multi-step workflow to mouse-liver samples and compared the two reported metabolite candidates with standards. AI proposed annotations, while standard-based chromatographic and spectral matching supported the assignments.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/42009661/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.